Top Analyst Upgrades and Downgrades: Athenahealth, Baker Hughes, Cisco, LinkedIn, Orbital-ATK, Tableau and Many More

February 8, 2016 by Jon C. Ogg

Stocks were getting pounded on Monday after a rough Friday, on the continuation of oil and a weak Europe, even as China was closed for Chinese New Year. The stock market volatility continues, and investors still seem eager to sell into rallies rather than the trend of buying every dip, as seen in the prior four years.

24/7 Wall St. reviews dozens of analyst reports each morning. The goal is to find new investing and trading ideas for its readers. Some of these analyst reports are on stocks to buy, while other reports cover stocks to sell or to avoid.

These are the top analyst upgrades, downgrades and initiations seen on Monday, February 8, 2016.

Athenahealth Inc. (NASDAQ: ATHN) was raised to Buy from Hold with a $160 price target (versus a $124.00 prior close) at Topeka Capital Markets. Athenahealth has a consensus analyst price target of $159.11 and a 52-week trading range of $110.68 to $170.42.

Baker Hughes Inc. (NYSE: BHI) was downgraded to Equal Weight from Overweight and the price target was cut to $47 from $59 (versus a $44.85 close) at Morgan Stanley. The consensus price target is $57.92, and the 52-week range is $37.58 to $70.45.

Cisco Systems Inc. (NASDAQ: CSCO) was maintained as Buy but was removed from the Conviction Buy list at Goldman Sachs, and the firm cut Cisco’s price target to $32 from $35. It was also maintained as Hold but the price target was cut to $26.00 from $29.50 at Jefferies, which sees Cisco’s risk/reward getting better after the recent drop in its share price, but the firm said it is cautious in a difficult environment and possibility of reduced April guidance.